Biodistribution of [F-18]FES in patients with metastatic ER plus breast cancer undergoing treatment with the novel selective estrogen receptor degrader G1T48

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
JournalJournal of Nuclear Medicine
Volume61
Publication statusPublished - 1 May 2020

Cite this